secwatch.observer — SEC 8-K summary
======================================

Issuer:     TherapeuticsMD, Inc. (TXMD)
CIK:        0000025743
Form:       8-K
Filed at:   2022-05-09T23:59:59+00:00
Accession:  0001564590-22-018687
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.03, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TherapeuticsMD effects 1-for-50 reverse stock split; authorized shares cut to 12M
--------------------------------------------------------------------------------

- Reverse split effective May 6, 2022; every 50 shares become 1 share.
- Authorized shares reduced from 600M to 12M; fractional shares rounded up.
- Trading on split-adjusted basis under TXMD begins May 9, 2022.
- No stockholder approval required under Nevada law.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/25743/000156459022018687/0001564590-22-018687-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/25743/000156459022018687/txmd-8k_20220503.htm
  HTML page:      https://secwatch.observer/filing/0001564590-22-018687

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer